-
公开(公告)号:US06552188B2
公开(公告)日:2003-04-22
申请号:US09893699
申请日:2001-06-29
申请人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Takeshi Doi , Yoshinori Kyotani
发明人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Takeshi Doi , Yoshinori Kyotani
IPC分类号: A61K31496
CPC分类号: C07D213/81 , C07D213/36 , C07D213/82 , C07D401/12
摘要: Cyclic diamine compounds of formula (1) are disclosed: wherein A is (CH2)n, (CH2)n—CH═CH, CO—(CH2)n or CO—(CH2)n—CH═CH, in which n is a number of 0 to 3; Z represents a formula (2) or (3): in which R1, R2, R4, R5 and R6 are individually a hydrogen atom, alkyl group, alkoxy group, halogen atom or nitro group; R3is a hydrogen atom, alkyl group, alkoxy group, halogen atom, nitro group, naphthyl group, or phenyl group which may be substituted by 1 to 3 substituents selected from the group consisting of alkyl groups, alkoxy groups, halogen atoms, a nitro group and a phenyl group; and X and Y are individually CH or a nitrogen atom; and m is 1 or 2; an acid-addition salt thereof, or a hydrate thereof, and a medicine containing such a compound.
摘要翻译: 公开了式(1)的环二胺化合物:其中A是(CH 2)n,(CH 2)n -CH = CH,CO-(CH 2)n或CO-(CH 2)n -CH = CH,其中n是 数字0到3; Z表示式(2)或(3):其中R1,R2,R4,R5和R6分别为氢原子,烷基,烷氧基,卤素原子或硝基; R3是氢原子,烷基,烷氧基,卤素原子,硝基,萘基或可以被1〜3个选自烷基,烷氧基,卤原子,硝基的取代基取代的苯基 和苯基; X和Y分别是CH或氮原子; m为1或2;其酸加成盐或其水合物,以及含有这种化合物的药物。
-
2.
公开(公告)号:US06498169B1
公开(公告)日:2002-12-24
申请号:US09983928
申请日:2001-10-26
申请人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Takeshi Doi , Yoshinori Kyotani , Masao Ohkuchi
发明人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Takeshi Doi , Yoshinori Kyotani , Masao Ohkuchi
IPC分类号: A61K314545
CPC分类号: C07D401/06 , A61K31/4545 , C07D211/58 , C07D401/12 , C07D401/14 , C07D403/14
摘要: A cyclic amine compound represented by the following general formula (1): wherein, R1, R2 and R3 each independently represent a hydrogen atom or an alkoxy group; W1 an W2 each independently represent N or CH; X represents O, NR4, CONR4 or NR4CO; R4 each independently represents a hydrogen atom, or an alkyl, aryl, heteroaryl, aralkyl, or heteroalkyl group; and l, m and n each represents a number of 0 to 1, a salt thereof and a hydrate thereof are provided. These compounds have inhibitory effects on both cell adhesion and cell infiltration and are useful as anti-asthmatic agents, anti-allergic agents, anti-rheumatic agents, anti-arteriosclerotic agents, anti-inflammatory agents, anti-Sjogren's syndrome agents or the like.
摘要翻译: 由以下通式(1)表示的环胺化合物:其中,R 1,R 2和R 3各自独立地表示氢原子或烷氧基; W 1,W 2各自独立地表示N或CH; X表示O,NR 4,CONR 4或 NR4CO; R4各自独立地表示氢原子,或烷基,芳基,杂芳基,芳烷基或杂烷基; 和l,m和n各自表示0至1的数,其盐和其水合物。这些化合物对细胞粘附和细胞浸润均具有抑制作用,可用作抗哮喘剂,抗过敏剂, 抗风湿剂,抗动脉硬化剂,抗炎剂,抗干燥素综合征剂等。
-
3.
公开(公告)号:US06867221B2
公开(公告)日:2005-03-15
申请号:US10191534
申请日:2002-07-10
申请人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Takeshi Doi , Yoshinori Kyotani , Masao Ohkuchi
发明人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Takeshi Doi , Yoshinori Kyotani , Masao Ohkuchi
IPC分类号: A61K31/4545 , A61P9/10 , A61P11/06 , A61P29/00 , A61P37/08 , A61P43/00 , C07D211/58 , C07D211/62 , C07D213/38 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/14 , C07D405/14
CPC分类号: C07D401/06 , A61K31/4545 , C07D211/58 , C07D211/62 , C07D213/38 , C07D401/12 , C07D401/14 , C07D403/14 , C07D405/14
摘要: A cyclic amine compound represented by the following general formula (1): wherein, R1, R2 and R3 each independently represent a hydrogen atom or an alkoxy group; W1 and W2 each independently represent N or CH; X represents O, NR4, CONR4 or NR4CO; R4 represents a hydrogen atom, or an alkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl group; and l, m and n each represents a number of 0 or 1, a salt thereof and a hydrate thereof are provided. These compounds have inhibitory effects on both cell adhesion and cell infiltration and are useful as anti-asthmatic agents, anti-allergic agents, anti-rheumatic agents, anti-arteriosclerotic agents, anti-inflammatory agents, anti-Sjogren's syndrome agents or the like.
摘要翻译: 由以下通式(1)表示的环胺化合物:其中,R 1,R 2和R 3各自独立地表示氢原子或烷氧基; W 1和W 2均为氢原子, 各自独立地表示N或CH; X表示O,NR 4,CONR 4或NR 4 CO; R 4表示氢原子或烷基,芳基,杂芳基,芳烷基或杂芳烷基; 和l,m和n各自表示0或1的数,其盐和其水合物。这些化合物对细胞粘附和细胞浸润都具有抑制作用,并且可用作抗哮喘剂,抗过敏剂, 抗风湿剂,抗动脉硬化剂,抗炎剂,抗干燥素综合征剂等。
-
4.
公开(公告)号:US06605620B1
公开(公告)日:2003-08-12
申请号:US10107180
申请日:2002-03-28
申请人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Takeshi Doi , Yoshinori Kyotani , Masao Ohkuchi
发明人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Takeshi Doi , Yoshinori Kyotani , Masao Ohkuchi
IPC分类号: A61K314545
CPC分类号: C07D401/06 , C07D211/58 , C07D213/38 , C07D401/12 , C07D401/14
摘要: A cyclic amine compound by the following general formula (1): wherein, R1, R2 and R3 each independently represent a hydrogen atom or an alkoxy group W1 and W2 each independently represent N or CH; X represents O, NR4, CONR4 or NR4CO; R4 represents a hydrogen atom, or an alkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl group; and l, m and n each represents a number of 0 or 1, a salt thereof and a hydrate thereof are provided. These compounds have inhibitory effects on both cell adhesion and cell infiltration and are useful as anti-asthmatic agents, anti-allergic agents, anti-rheumatic agents, anti-arteriosclerotic agents, anti-inflammatory agents, anti-Sjogren's syndrome agents or the like.
摘要翻译: 通式(1)表示的环状胺化合物:其中,R 1,R 2和R 3各自独立地表示氢原子或烷氧基,W 1和W 2各自独立地表示N或CH; X表示O,NR 4,CONR 4或NR 4 CO; R 4 表示氢原子,或烷基,芳基,杂芳基,芳烷基或杂芳烷基; 和l,m和n各自表示0或1的数,其盐和其水合物。 这些化合物对细胞粘附和细胞浸润具有抑制作用,并且可用作抗哮喘药,抗过敏剂,抗风湿剂,抗动脉硬化剂,抗炎剂,抗干燥素综合征剂等。
-
5.
公开(公告)号:US06395753B1
公开(公告)日:2002-05-28
申请号:US09941684
申请日:2001-08-30
申请人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Takeshi Doi , Yoshinori Kyotani , Masao Ohkuchi
发明人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Takeshi Doi , Yoshinori Kyotani , Masao Ohkuchi
IPC分类号: A61K314545
CPC分类号: C07D401/06 , A61K31/4545 , C07D211/58 , C07D401/12 , C07D401/14 , C07D403/14
摘要: A cyclic amine compound represented by the following general formula (1): wherein, R1, R2 and R3 each independently represent a hydrogen atom or an alkoxy group; W1 and W2 each independently represent N or CH; X represents O, NR4, CONR4 or NR4CO; R4 each independently represents a hydrogen atom, or an alkyl, aryl, heteroaryl, aralkyl, or heteroaralkyl group; and l, m and n each represents a number of 0 or 1, a salt thereof and a hydrate thereof are provided. These compounds have inhibitory effects on both cell adhesion and cell infiltration and are useful as anti-asthmatic agents, anti-allergic agents, anti-rheumatic agents, anti-arteriosclerotic agents, anti-inflammatory agents, anti-Sjogren's syndrome agents or the like.
摘要翻译: 由以下通式(1)表示的环胺化合物:其中,R1,R2和R3各自独立地表示氢原子或烷氧基; W1和W2各自独立地表示N或CH; X表示O,NR4,CONR4或 NR4CO; R4各自独立地表示氢原子,或烷基,芳基,杂芳基,芳烷基或杂芳烷基; 和l,m和n各自表示0或1的数,其盐和其水合物。这些化合物对细胞粘附和细胞浸润都具有抑制作用,并且可用作抗哮喘剂,抗过敏剂, 抗风湿剂,抗动脉硬化剂,抗炎剂,抗干燥素综合征剂等。
-
公开(公告)号:US06509329B1
公开(公告)日:2003-01-21
申请号:US09893697
申请日:2001-06-29
申请人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Takeshi Doi , Yoshinori Kyotani
发明人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Takeshi Doi , Yoshinori Kyotani
IPC分类号: C07D25112
CPC分类号: C07D295/096 , A61K31/495 , A61K31/496 , A61K31/506 , A61K31/551 , C07D213/38
摘要: A cyclic diamine compound of formula (1): wherein A is a single bond or C≡C; X and Y are individually CH or a nitrogen atom; m is 1 or 2; and n is a number of 1 to 5; an acid-addition salt thereof, or a hydrate thereof. The compound has excellent inhibitory effects on both cell adhesion and cell infiltration and is useful as a medicine for prevention or treatment of diseases such as allergy, asthma, rheumatism, arteriosclerosis and inflammation.
摘要翻译: 式(1)的环状二胺化合物:其中A是单键或C = C; X和Y分别是CH或氮原子; m为1或2; n为1〜5的数; 其酸加成盐或其水合物。 该化合物对细胞粘附和细胞浸润具有优异的抑制作用,可用作预防或治疗诸如过敏,哮喘,风湿病,动脉硬化和炎症等疾病的药物。
-
公开(公告)号:US07135473B2
公开(公告)日:2006-11-14
申请号:US10639457
申请日:2003-08-13
申请人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Takeshi Doi , Yoshinori Kyotani
发明人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Takeshi Doi , Yoshinori Kyotani
IPC分类号: A61K31/497 , A61P37/00 , C07D239/00 , C07D401/00 , C07D403/00
CPC分类号: C07D263/56 , A61K31/4184 , A61K31/423 , A61K31/496 , A61K31/517 , A61K31/551 , C07D209/14 , C07D215/12 , C07D235/14 , C07D239/74 , C07D243/06 , C07D277/64 , C07D295/096 , C07D307/81 , C07D333/58 , C07D401/14 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14
摘要: A cyclic diamine compound of formula (1): wherein R1 and R2 are individually a hydrogen atom or a methoxy group, provided R1 is a methoxy group when R2 is a hydrogen atom, or a hydrogen atom when R2 is a methoxy group; A is an oxygen atom, a sulfur atom, CH═CH, CH═N or NR3, in which R3 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; B is a nitrogen atom, CH or CR4, in which R4 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; m is 1 or 2; and n is a number of 1 to 5, an acid-addition salt thereof, or a hydrate thereof. The compound has inhibitory effects on cell adhesion and is useful for treatment of allergy, asthma, rheumatism, arteriosclerosis, and inflammation.
摘要翻译: 式(1)的环状二胺化合物:其中R 1和R 2各自独立地为氢原子或甲氧基,条件是R 1, 当R 2为氢原子时为甲氧基,或当R 2为甲氧基时为氢原子; A是氧原子,硫原子,CH-CH,CH-N或NR 3,其中R 3是氢原子,或低级烷基羟基 低级烷基,低级烷氧基低级烷基,芳基或芳基低级烷基; B是氮原子,CH或CR 4,其中R 4是氢原子,或低级烷基,羟基低级烷基,低级烷氧基低级烷基,芳基或 芳基低级烷基; m为1或2; n为1〜5的数,其酸加成盐或其水合物。 该化合物对细胞粘附具有抑制作用,可用于治疗过敏,哮喘,风湿病,动脉硬化和炎症。
-
公开(公告)号:US06632810B2
公开(公告)日:2003-10-14
申请号:US09893696
申请日:2001-06-29
申请人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Takeshi Doi , Yoshinori Kyotani
发明人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Takeshi Doi , Yoshinori Kyotani
IPC分类号: A61K3155
CPC分类号: C07D263/56 , A61K31/4184 , A61K31/423 , A61K31/496 , A61K31/517 , A61K31/551 , C07D209/14 , C07D215/12 , C07D235/14 , C07D239/74 , C07D243/06 , C07D277/64 , C07D295/096 , C07D307/81 , C07D333/58 , C07D401/14 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14
摘要: A cyclic diamine compound of formula (1): wherein R1 and R2 are individually a hydrogen atom or a methoxy group, provided R1 is a methoxy group when R2 is a hydrogen atom, or a hydrogen atom when R2 is a methoxy group; A is an oxygen atom, a sulfur atom, CH═CH, CH═N or NR3, in which R3 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; B is a nitrogen atom, CH or CR4, in which R4 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl, aryl or aryl lower alkyl group; m is 1 or 2; and n is a number of 1 to 5, an acid-addition salt thereof, or a hydrate thereof. The compound has inhibitory effects on cell adhesion and is useful for treatment of allergy, asthma, rheumatism, arteriosclerosis, and inflammation.
摘要翻译: 式(1)的环状二胺化合物:其中R
PDAT>和R 2 SP> PDAT>分别为氢原子或甲氧基,条件是R 当R <2 SP> 是氢原子时,当R <2 SP>时, <1 SP> 是甲氧基 是甲氧基; A是氧原子,硫原子,CH = CH,CH = N或NR <3 SP> ,其中R <3 SP> 原子或低级烷基,羟基低级烷基,低级烷氧基低级烷基,芳基或芳基低级烷基; B是氮原子,CH或CR <4 SP> ,其中R <4 SP> 是氢原子或低级烷基羟基低级烷基 ,低级烷氧基低级烷基,芳基或芳基低级烷基; m为1或2; n为1〜5的数,或其酸加成盐或其水合物。 该化合物对细胞粘附具有抑制作用,可用于治疗过敏,哮喘,风湿病,动脉硬化和炎症。 PTEXT> -
公开(公告)号:US06472386B1
公开(公告)日:2002-10-29
申请号:US09893682
申请日:2001-06-29
申请人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Takeshi Doi , Yoshinori Kyotani
发明人: Tatsuhiko Kodama , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Takeshi Doi , Yoshinori Kyotani
IPC分类号: A61K31551
CPC分类号: C07D231/12 , C07D233/64 , C07D261/08 , C07D263/32 , C07D277/28 , C07D277/46 , C07D333/20 , C07D401/14 , C07D403/14 , C07D409/14 , C07D413/14 , C07D417/14
摘要: A compound of formula (1): wherein A is a single bond, C≡C, CONH or NHCO; W is a carbon atom or a nitrogen atom; X is CH, a nitrogen atom, an oxygen atom or a sulfur atom; Y is CH, CHR1, in which R1 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy-lower-alkyl, aryl, aryl-lower-alkyl or heteroaryl-lower-alkyl group, a nitrogen atom, an oxygen atom, a sulfur atom or NR2, in which R2 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy-lower-alkyl, aryl, aryl-lower-alkyl or heteroaryl-lower-alkyl group; Z is a nitrogen atom, an oxygen atom, a sulfur atom, CH or NR3, in which R3 is a hydrogen atom, or a lower alkyl, hydroxy lower alkyl, lower alkoxy-lower-alkyl, aryl, aryl-lower-alkyl or heteroaryl-lower-alkyl group; m is 1 or 2; and n is a number of 1 to 5, with the proviso that one or two of W, X, Y and Z are heteroatoms; an acid-addition salt thereof, or a hydrate thereof. The compounds have inhibitory effects on cell adhesion and are useful for prevention or treatment of diseases such as allergy, asthma, rheumatism, arteriosclerosis and inflammation.
摘要翻译: 式(1)的化合物:其中A是单键,C = C,CONH或NHCO; W是碳原子或氮原子; X是CH,氮原子,氧原子或硫原子; Y是CH,CHR1,其中R1是氢原子,或低级烷基,羟基低级烷基,低级烷氧基 - 低级 - 烷基,芳基,芳基 - 低级 - 烷基或杂芳基 - 低级 - 烷基,氮原子, 氧原子,硫原子或NR 2,其中R2是氢原子,或低级烷基,羟基低级烷基,低级烷氧基 - 低级 - 烷基,芳基,芳基 - 低级 - 烷基或杂芳基 - 低级 - 烷基; Z是氮原子,氧原子,硫原子,CH或NR 3,其中R3是氢原子,或低级烷基,羟基低级烷基,低级烷氧基 - 低级 - 烷基,芳基,芳基 - 低级 - 烷基或 杂芳基 - 低级烷基; m为1或2; 并且n是1至5的数,条件是W,X,Y和Z中的一个或两个是杂原子; 其酸加成盐或其水合物。 这些化合物对细胞粘附具有抑制作用,可用于预防或治疗诸如过敏,哮喘,风湿病,动脉硬化和炎症等疾病。
-
公开(公告)号:US20050176764A1
公开(公告)日:2005-08-11
申请号:US10510759
申请日:2003-04-11
申请人: Chikage Mataki , Tatsuhiko Kodama , Takeshi Doi , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Masao Ohkuch
发明人: Chikage Mataki , Tatsuhiko Kodama , Takeshi Doi , Masahiro Tamura , Toshiaki Oda , Yukiyoshi Yamazaki , Masahiro Nishikawa , Shunji Takemura , Masao Ohkuch
IPC分类号: C07D295/12 , A61K31/445 , A61K31/4545 , A61K48/00 , A61P35/00 , A61P43/00 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/14 , C07D491/10
CPC分类号: C07D401/06 , A61K31/445 , A61K31/4545 , C04B35/632 , C07D295/12 , C07D401/12 , C07D401/14 , C07D405/14 , C07D491/10
摘要: Abstract The present invention is directed to a method for treating cancer, a method for inhibiting histone deacetylase, and a method for facilitating gene therapy, comprising administering an effective amount of a cyclic amine compound represented by the following formula (1):(wherein R1, R2, and R3 each independently represent a hydrogen atom, a halogen atom, a hydroxy group, an alkyl group, a halogen-substituted alkyl group, an alkoxy group, an alkylthio group, a carboxyl group, an alkoxycarbonyl group, or an alkanoyl group; W1 and W2, which are identical to or different from each other, represent N or CH; X represents O, NR4, CONR4, or NR4CO; R4 represents a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted heteroaralkyl group; and l, m, and n each represent a number of 0 or 1), a salt thereof, or a hydrate thereof.208
摘要翻译: 摘要本发明涉及一种治疗癌症的方法,一种抑制组蛋白脱乙酰酶的方法和一种促进基因治疗的方法,包括给予有效量的由下式(1)表示的环胺化合物:(其中R1 R 2和R 3各自独立地表示氢原子,卤素原子,羟基,烷基,卤素取代的烷基,烷氧基,烷硫基,羧基,烷氧基羰基或烷酰基 基团W 1和W 2彼此相同或不同,表示N或CH; X表示O,NR 4,CONR 4或NR 4 CO; R 4表示氢原子,烷基,烯基,炔基, 取代或未取代的芳基,取代或未取代的杂芳基,取代或未取代的芳烷基或取代或未取代的杂芳烷基; l,m和n各自表示0或1的数),其盐, o 其水合物
-
-
-
-
-
-
-
-
-